MX388182B - Composición para el alivio de la boca seca. - Google Patents

Composición para el alivio de la boca seca.

Info

Publication number
MX388182B
MX388182B MX2017007597A MX2017007597A MX388182B MX 388182 B MX388182 B MX 388182B MX 2017007597 A MX2017007597 A MX 2017007597A MX 2017007597 A MX2017007597 A MX 2017007597A MX 388182 B MX388182 B MX 388182B
Authority
MX
Mexico
Prior art keywords
composition
dry mouth
mouth relief
maintaining
mucosal surface
Prior art date
Application number
MX2017007597A
Other languages
English (en)
Other versions
MX2017007597A (es
Inventor
Jerome E Swanson
Original Assignee
Elevate Oral Care Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elevate Oral Care Llc filed Critical Elevate Oral Care Llc
Publication of MX2017007597A publication Critical patent/MX2017007597A/es
Publication of MX388182B publication Critical patent/MX388182B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/547—Chelates, e.g. Gd-DOTA or Zinc-amino acid chelates; Chelate-forming compounds, e.g. DOTA or ethylenediamine being covalently linked or complexed to the pharmacologically- or therapeutically-active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una formulación mucoadhesiva que contiene un clatrato incorporado que encierra moléculas de agua provee un medio efectivo para, no solo proveyendo humedad a, y manteniendo la humedad sobre, la superficie de una mucosa, sino también manteniendo una alta concentración de un alcohol de azúcar in situ sobre la superficie de la mucosa por periodos extendidos.
MX2017007597A 2014-12-10 2015-11-20 Composición para el alivio de la boca seca. MX388182B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462089942P 2014-12-10 2014-12-10
PCT/US2015/061743 WO2016094054A1 (en) 2014-12-10 2015-11-20 Composition for the relief of dry mouth

Publications (2)

Publication Number Publication Date
MX2017007597A MX2017007597A (es) 2018-03-01
MX388182B true MX388182B (es) 2025-03-19

Family

ID=56107939

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017007597A MX388182B (es) 2014-12-10 2015-11-20 Composición para el alivio de la boca seca.

Country Status (9)

Country Link
US (1) US10772908B2 (es)
EP (1) EP3229792B1 (es)
JP (1) JP6783244B2 (es)
AU (1) AU2015361122B2 (es)
CA (1) CA2970146C (es)
ES (1) ES2982077T3 (es)
MX (1) MX388182B (es)
PL (1) PL3229792T3 (es)
WO (1) WO2016094054A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016383713B2 (en) 2016-01-10 2023-10-12 Smilesonica Inc. Viscosity and stability modified ultrasound gel
CN105833278B (zh) * 2016-04-25 2018-05-08 北京嘉安医疗器械科技有限公司 用于治疗口腔干燥和口腔疾病的组合物
EP3585361A4 (en) * 2017-02-22 2020-12-23 Smilesonica Inc. ARTIFICIAL SALIVA, RELATED PROCESSES AND USES
EP4228588A1 (en) * 2020-10-15 2023-08-23 Advantage Silver Dental Arrest, LLC A thickened silver diamine fluoride composition

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3970747A (en) 1974-03-11 1976-07-20 Colgate-Palmolive Company Humectant sweetener
US4340583A (en) * 1979-05-23 1982-07-20 J. M. Huber Corporation High fluoride compatibility dentifrice abrasives and compositions
US4997654A (en) 1989-08-14 1991-03-05 Warner-Lambert Company Method for increasing salivation for xerostomia patients
US5496558A (en) 1993-03-02 1996-03-05 Block Drug Company Inc. Solid form xerostomia product
US5900230A (en) * 1997-08-18 1999-05-04 Squigle, Inc. Dental products to treat and prevent periodontal disease
EP1068871A1 (en) 1999-07-07 2001-01-17 Jean-Paul Perraudin Novel methods and medicament for treating infections diseases involving microbial biofilms
AU2005268926B2 (en) 2004-08-02 2011-10-13 Glaxosmithkline Consumer Healthcare (Uk) Ip Limited Novel composition for xerostomia
WO2009108713A2 (en) 2008-02-25 2009-09-03 Signum Biosciences, Inc. Topical compositions and methods utilizing peptides containing lipid-modified cysteine-containing peptides
US8735374B2 (en) 2009-07-31 2014-05-27 Intelgenx Corp. Oral mucoadhesive dosage form
JP5433355B2 (ja) 2009-09-16 2014-03-05 サンスター株式会社 口腔用組成物
US8658139B1 (en) * 2010-02-27 2014-02-25 Squigle, Inc. Prevention and treatment of oral diseases
WO2011130009A1 (en) 2010-04-14 2011-10-20 Isp Investments Inc. Oral care compositions
CA2800475C (en) 2010-06-23 2015-11-03 Colgate-Palmolive Company Therapeutic oral compositions
US20120053130A1 (en) * 2010-08-30 2012-03-01 Bristol-Myers Squibb Company Composition for enhancing absorption of a drug and method
CN103442698B (zh) 2010-12-16 2016-10-05 细胞基因公司 难溶性药物的控释口服剂量形式及其用途
MY161603A (en) 2010-12-23 2017-04-28 Colgate Palmolive Co Aqueous oral care composition comprising xanthan gum, cellulose gum and carbomer
US9458322B2 (en) 2011-09-23 2016-10-04 Emerald Hilton Davis, Llc Self-assembled nano-structure particle and method for preparing
SG11201402061UA (en) * 2011-12-15 2014-06-27 Colgate Palmolive Co Aqueous oral care compositions
US9724542B2 (en) 2012-10-12 2017-08-08 Premier Dental Products Company Remineralizing and desensitizing compositions, treatments and methods of manufacture

Also Published As

Publication number Publication date
CA2970146C (en) 2023-10-31
MX2017007597A (es) 2018-03-01
EP3229792C0 (en) 2024-02-07
JP2017537983A (ja) 2017-12-21
ES2982077T3 (es) 2024-10-14
AU2015361122B2 (en) 2020-12-17
EP3229792A4 (en) 2018-08-08
WO2016094054A1 (en) 2016-06-16
CA2970146A1 (en) 2016-06-16
PL3229792T3 (pl) 2024-06-10
JP6783244B2 (ja) 2020-11-11
EP3229792B1 (en) 2024-02-07
AU2015361122A1 (en) 2017-06-22
EP3229792A1 (en) 2017-10-18
US20170354676A1 (en) 2017-12-14
US10772908B2 (en) 2020-09-15

Similar Documents

Publication Publication Date Title
AR095233A1 (es) Métodos y composiciones para el control de malezas
MX2018004475A (es) Agentes biologicos y su uso en plantas.
MX391216B (es) Composicion farmaceutica que comprende un vector adenoviral.
SA517381769B1 (ar) توليد حمض بيروكسي فورميك من خلال فورمات كحول بولي هيدريك
BR112017006664A2 (pt) terapias de combinação
TWD185242S (zh) 集成的通用串行總線裝置延長線
MX381290B (es) Formulaciones de peróxido y métodos y aplicaciones para utilizarlas.
EA202090632A1 (ru) Способы и композиции для лечения расстройств с использованием фоллистатиновых полипептидов
EA201690280A1 (ru) Композиции и способы, относящиеся к выделенным эндофитам
EA201691429A1 (ru) МОДИФИЦИРОВАННЫЕ МЕНИНГОКОККОВЫЕ ПОЛИПЕПТИДЫ fHbp
EA201692552A1 (ru) МОДИФИЦИРОВАННЫЕ МЕНИНГОКОККОВЫЕ ПОЛИПЕПТИДЫ fHbp
MX381544B (es) Composición de células estromales mesenquimatosas para usare en el tratamiento de la sepsis en un sujeto.
PH12017500836A1 (en) Transdermal formulations
AR099500A1 (es) Composición para el desmucilaginado enzimático de aceite
MX374385B (es) Apilimod para uso en el tratamiento de melanoma.
WO2016079110A3 (en) Use of enzyme for cleaning
MX388182B (es) Composición para el alivio de la boca seca.
DK3356524T3 (da) Forøget genlevering til naturlige dræberceller, hæmatopoietiske stamceller og makrofager
AU2015267160A8 (en) Methods and compositions for preventing ischemia reperfusion injury in organs
DK3197046T3 (da) Selvforspændt output booster forstærker samt anvendelse deraf
AR103119A1 (es) Uso de elsiglutida para tratar mucositis gastrointestinal, incluyendo diarrea inducida por quimioterapia
AU358315S (en) Novelty sconce
CL2016002653A1 (es) Combinación farmacéutica que comprende brexpiprazol y nalmefeno; composición farmacéutica que los comprende; kit farmacéutico; y uso de la combinación para la prevención y tratamiento de un trastorno relacionado con sustancias como el alcohol.
MX380683B (es) Lisobactina para su uso en el tratamiento de la mastitis bovina.
EA201690709A1 (ru) Применение одипарцила в лечении мукополисахаридоза